Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-19

Clinical Trial Update: Long-Term Study of Nitisinone to Treat Alkaptonuria [Phase 2]

View source ↗

Summary

A Phase 2 long-term trial of nitisinone for alkaptonuria has completed, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitisinone (Nitisinone)

Snippet

Sponsor: National Human Genome Research Institute (NHGRI) | Conditions: Alkaptonuria | Phase 2 | Status: COMPLETED | Results posted: 2011-01-19